5-HT.sub.4 receptor agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544105, A61K 31535, C07D41312, C07D49808

Patent

active

056840039

ABSTRACT:
Compounds of formula (I) and pharmaceutically acceptable salts thereof are selective agonists for 5-HT.sub.4 receptors. ##STR1## wherein Ak is a C.sub.3 -C.sub.6 alkyl group, and R is a C.sub.2 -C.sub.6 alkyl group, a C.sub.3 -C.sub.6 alkenyl group, a C.sub.3 -C.sub.6 alkynyl group, a C.sub.3 -C.sub.7 cycloalkyl group or a C.sub.3 -C.sub.6 cycloalkylmethyl group.

REFERENCES:
patent: 5187166 (1993-02-01), Kikuchi et al.
patent: 5256656 (1993-10-01), Kikuchi et al.
Trends in Pharmacological Science, vol. 13, "The 5-HT.sub.4 Receptor: A Place in the Sun", Bockaert, et al. Apr. 1992, pp. 141-145.
J. Am. Chem. Soc., vol. 104, 6876-6877, (1982), Grochowski et al.
Naunyn-Schmiedeberg's Arch Pharmacol, "SDZ 205-557, A Selective, Surmountable Antagonist for 5-HT.sub.4 Receptors in the Isolated Guinea Pig Ileum", Buchheit, et al. (1992) pp. 387-393.
Nauyn-Schmiedeberg's Arch Pharmacol, "5-Hydroxytryptamine.sub.4, Receptors Mediate Relaxation of the Rat Oesophageal Tunica Muscularis Mucosae", Baxter, et al. (1991) pp. 439-446.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

5-HT.sub.4 receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-HT.sub.4 receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-HT.sub.4 receptor agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1833217

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.